These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 25418531

  • 1. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
    Candia R, Ruiz A, Torres-Robles R, Chávez-Tapia N, Méndez-Sánchez N, Arrese M.
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
    [Abstract] [Full Text] [Related]

  • 2. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A, Lorenzin M, Tadiotto G, Russo FP, Oliviero F, Felicetti M, D'Incà R, Favero M, Piaserico S, Doria A, Ramonda R.
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [Abstract] [Full Text] [Related]

  • 3. Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies.
    Bellinato F, Gisondi P, Mantovani A, Girolomoni G, Targher G.
    J Endocrinol Invest; 2022 Jul; 45(7):1277-1288. PubMed ID: 35147926
    [Abstract] [Full Text] [Related]

  • 4. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.
    Madanagobalane S, Anandan S.
    Australas J Dermatol; 2012 Aug; 53(3):190-7. PubMed ID: 22672067
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis.
    Hu J, Shao Y, Gui C, Xiao Y, Li L, Li Z.
    Medicine (Baltimore); 2024 May 03; 103(18):e38007. PubMed ID: 38701269
    [Abstract] [Full Text] [Related]

  • 6. Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk.
    Romero-Pérez D, Belinchón-Romero I, Bellot P, Francés R, Marco F, Ramos-Rincón JM.
    Australas J Dermatol; 2019 Nov 03; 60(4):e304-e310. PubMed ID: 31236937
    [Abstract] [Full Text] [Related]

  • 7. Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
    Mantovani A, Gisondi P, Lonardo A, Targher G.
    Int J Mol Sci; 2016 Feb 05; 17(2):217. PubMed ID: 26861300
    [Abstract] [Full Text] [Related]

  • 8. The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
    Xu X, Su L, Gao Y, Ding Y.
    PLoS One; 2017 Feb 05; 12(1):e0169952. PubMed ID: 28099469
    [Abstract] [Full Text] [Related]

  • 9. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
    Miele L, Vallone S, Cefalo C, La Torre G, Di Stasi C, Vecchio FM, D'Agostino M, Gabrieli ML, Vero V, Biolato M, Pompili M, Gasbarrini G, Rapaccini G, Amerio P, De Simone C, Grieco A.
    J Hepatol; 2009 Oct 05; 51(4):778-86. PubMed ID: 19664838
    [Abstract] [Full Text] [Related]

  • 10. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
    Marventano S, Salomone F, Godos J, Pluchinotta F, Del Rio D, Mistretta A, Grosso G.
    Clin Nutr; 2016 Dec 05; 35(6):1269-1281. PubMed ID: 27060021
    [Abstract] [Full Text] [Related]

  • 11. Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.
    Bellinato F, Goio I, Malara G, Rosato A, Targher G, Girolomoni G, Gisondi P.
    J Cutan Med Surg; 2022 Dec 05; 26(3):249-255. PubMed ID: 34894782
    [Abstract] [Full Text] [Related]

  • 12. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H, Craig D, Barker R, Spiers G, Stow D, Anstee QM, Hanratty B.
    PLoS Med; 2020 Apr 05; 17(4):e1003100. PubMed ID: 32353039
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic.
    Roberts KK, Cochet AE, Lamb PB, Brown PJ, Battafarano DF, Brunt EM, Harrison SA.
    Aliment Pharmacol Ther; 2015 Feb 05; 41(3):293-300. PubMed ID: 25521607
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Non-alcoholic fatty liver disease and psoriasis - is there a shared proinflammatory network?
    Heitmann J, Frings VG, Geier A, Goebeler M, Kerstan A.
    J Dtsch Dermatol Ges; 2021 Apr 05; 19(4):517-528. PubMed ID: 33768700
    [Abstract] [Full Text] [Related]

  • 19. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
    Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, Hultcrantz R, Hagström H, Yoon SK, Charatcharoenwitthaya P, George J, Barrera F, Hafliðadóttir S, Björnsson ES, Armstrong MJ, Hopkins LJ, Gao X, Francque S, Verrijken A, Yilmaz Y, Lindor KD, Charlton M, Haring R, Lerch MM, Rettig R, Völzke H, Ryu S, Li G, Wong LL, Machado M, Cortez-Pinto H, Yasui K, Cassader M.
    PLoS Med; 2014 Jul 05; 11(7):e1001680. PubMed ID: 25050550
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.